Esperion Therapeutics, Inc. ($ESPR)
Filing Information
| Accession Number | 0001628280-26-018186 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
468,700
Total Value
$0.00
P&L
+inf% (+$1,195,185.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 13, 2026 | Grant/Award | 247,430 | $0.00 | $0.00 | 720,026 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (right to buy) | Derivative | Mar 13, 2026 | Grant/Award | 221,270 | $0.00 | $0.00 | 221,270 | Direct | โ | View Details |